EX-99.1 3 fy17188-krecastexhibit991r.htm EXHIBIT 99.1 REVISED SELECTED FINANCIAL DATA Exhibit

EXHIBIT 99.1 Revised Selected Financial Data.
The information required by this item is incorporated by reference to Note 1 and Note 2 in Exhibit 99.3 Revised Consolidated Financial Statements and Accompanying Notes. For further details behind the business drivers for recent results presented below, see Exhibit 99.2 Revised Management's Discussion and Analysis.
Financial Summary (Unaudited)
Amounts in millions, except per share amounts
2018
 
2017
 
2016
 
2015
 
2014
 
2013
Net sales
$
66,832

 
$
65,058

 
$
65,299

 
$
70,749

 
$
74,401

 
$
73,910

Gross profit
32,400

 
32,420

 
32,275

 
33,649

 
35,356

 
35,910

Operating income
13,363

 
13,766

 
13,258

 
11,056

 
13,958

 
13,303

Net earnings from continuing operations
9,861

 
10,194

 
10,027

 
8,287

 
10,658

 
10,346

Net earnings/(loss) from discontinued operations
—

 
5,217

 
577

 
(1,143
)
 
1,127

 
1,056

Net earnings attributable to Procter & Gamble
9,750

 
15,326

 
10,508

 
7,036

 
11,643

 
11,312

Net earnings margin from continuing operations
14.8
%
 
15.7
%
 
15.4
%
 
11.7
%
 
14.3
%
 
14.0
%
Basic net earnings per common share: (1)
 
 
 
 
 
 
 
 
 
 
 
Earnings from continuing operations
$
3.75

 
$
3.79

 
$
3.59

 
$
2.92

 
$
3.78

 
$
3.65

Earnings/(loss) from discontinued operations
—

 
2.01

 
0.21

 
(0.42
)
 
0.41

 
0.39

Basic net earnings per common share
$
3.75

 
$
5.80

 
$
3.80

 
$
2.50

 
$
4.19

 
$
4.04

Diluted net earnings per common share: (1)
 
 
 
 
 
 
 
 
 
 
 
Earnings from continuing operations
$
3.67

 
$
3.69

 
$
3.49

 
$
2.84

 
$
3.63

 
$
3.50

Earnings/(loss) from discontinued operations
—

 
1.90

 
0.20

 
(0.40
)
 
0.38

 
0.36

Diluted net earnings per common share
$
3.67

 
$
5.59

 
$
3.69

 
$
2.44

 
$
4.01

 
$
3.86

Dividends per common share
$
2.79

 
$
2.70

 
$
2.66

 
$
2.59

 
$
2.45

 
$
2.29

Research and development expense
$
1,908

 
$
1,874

 
$
1,879

 
$
1,991

 
$
1,910

 
$
1,867

Advertising expense
7,103

 
7,118

 
7,243

 
7,180

 
7,867

 
8,188

Total assets
118,310

 
120,406

 
127,136

 
129,495

 
144,266

 
139,263

Capital expenditures
3,717

 
3,384

 
3,314

 
3,736

 
3,848

 
4,008

Long-term debt
20,863

 
18,038

 
18,945

 
18,327

 
19,807

 
19,111

Shareholders' equity
$
52,883

 
$
55,778

 
$
57,983

 
$
63,050

 
$
69,976

 
$
68,709

(1) 
Basic net earnings per common share and Diluted net earnings per common share are calculated based on Net earnings attributable to Procter & Gamble.